ArticleInfectious diseases and therapy2021

Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials.

Pedro L Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.